BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 25096571)

  • 1. PIM1 kinase phosphorylates the human transcription factor FOXP3 at serine 422 to negatively regulate its activity under inflammation.
    Li Z; Lin F; Zhuo C; Deng G; Chen Z; Yin S; Gao Z; Piccioni M; Tsun A; Cai S; Zheng SG; Zhang Y; Li B
    J Biol Chem; 2014 Sep; 289(39):26872-26881. PubMed ID: 25096571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro.
    Yates J; Rovis F; Mitchell P; Afzali B; Tsang J; Garin M; Lechler RI; Lombardi G; Garden OA
    Int Immunol; 2007 Jun; 19(6):785-99. PubMed ID: 17545278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.
    Scholzen A; Mittag D; Rogerson SJ; Cooke BM; Plebanski M
    PLoS Pathog; 2009 Aug; 5(8):e1000543. PubMed ID: 19680449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and expression of inhibitory markers of CD4(+) CD25(+) FOXP3(+) regulatory T cells in patients with common variable immunodeficiency.
    Arandi N; Mirshafiey A; Abolhassani H; Jeddi-Tehrani M; Edalat R; Sadeghi B; Shaghaghi M; Aghamohammadi A
    Scand J Immunol; 2013 May; 77(5):405-12. PubMed ID: 23432692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation.
    Lozano T; Villanueva L; Durántez M; Gorraiz M; Ruiz M; Belsúe V; Riezu-Boj JI; Hervás-Stubbs S; Oyarzábal J; Bandukwala H; Lourenço AR; Coffer PJ; Sarobe P; Prieto J; Casares N; Lasarte JJ
    J Immunol; 2015 Oct; 195(7):3180-9. PubMed ID: 26324768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
    Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
    J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foxp3(+) T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation.
    Yang BH; Hagemann S; Mamareli P; Lauer U; Hoffmann U; Beckstette M; Föhse L; Prinz I; Pezoldt J; Suerbaum S; Sparwasser T; Hamann A; Floess S; Huehn J; Lochner M
    Mucosal Immunol; 2016 Mar; 9(2):444-57. PubMed ID: 26307665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease.
    Peterson LB; Bell CJM; Howlett SK; Pekalski ML; Brady K; Hinton H; Sauter D; Todd JA; Umana P; Ast O; Waldhauer I; Freimoser-Grundschober A; Moessner E; Klein C; Hosse RJ; Wicker LS
    J Autoimmun; 2018 Dec; 95():1-14. PubMed ID: 30446251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-1R1 is expressed on both Helios(+) and Helios(-) FoxP3(+) CD4(+) T cells in the rheumatic joint.
    Müller M; Herrath J; Malmström V
    Clin Exp Immunol; 2015 Oct; 182(1):90-100. PubMed ID: 26076982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4.
    Pletinckx K; Vaeth M; Schneider T; Beyersdorf N; Hünig T; Berberich-Siebelt F; Lutz MB
    Eur J Immunol; 2015 Feb; 45(2):480-91. PubMed ID: 25382658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypomethylation at the regulatory T cell-specific demethylated region in CD25hi T cells is decoupled from FOXP3 expression at the inflamed site in childhood arthritis.
    Bending D; Pesenacker AM; Ursu S; Wu Q; Lom H; Thirugnanabalan B; Wedderburn LR
    J Immunol; 2014 Sep; 193(6):2699-708. PubMed ID: 25092890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Modulation of Regulatory T Cells by IL-2.
    Moon BI; Kim TH; Seoh JY
    PLoS One; 2015; 10(11):e0141864. PubMed ID: 26529512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTD-hFOXP3 protein acts as an immune regulator to convert human CD4(+)CD25(-) T cells to regulatory T-like cells.
    Liu X; Xu X; Lin X; Tian Y; Ji B; Xia S; Xu S; Yin Q; Zhang M; Jiao Z; Wang S; Xu H; Shao Q
    J Cell Biochem; 2012 Dec; 113(12):3797-809. PubMed ID: 22806628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Suppressive Activity of Regulatory T Cells in the Microenvironment of Malignant Pleural Effusions.
    Budna J; Kaczmarek M; Kolecka-Bednarczyk A; Spychalski Ł; Zawierucha P; Goździk-Spychalska J; Nowicki M; Batura-Gabryel H; Sikora J
    J Immunol Res; 2018; 2018():9876014. PubMed ID: 29785404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.
    Méndez-Lagares G; Pozo-Balado MM; Genebat M; García Pergañeda A; Leal M; Pacheco YM
    J Infect Dis; 2012 May; 205(10):1501-9. PubMed ID: 22457273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of IL-37 contributes to the immunosuppressive property of human CD4+CD25+ regulatory T cells.
    Shuai X; Wei-min L; Tong YL; Dong N; Sheng ZY; Yao YM
    Sci Rep; 2015 Sep; 5():14478. PubMed ID: 26411375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
    Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nilotinib on regulatory T cells: the dose matters.
    Fei F; Yu Y; Schmitt A; Rojewski MT; Chen B; Greiner J; Götz M; Bunjes D; Schmitt M
    Mol Cancer; 2010 Jan; 9():22. PubMed ID: 20113470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
    Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
    Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.